Swiss Chemicals Stock News

Earlier this month, Galderma announced that the U.S. Food and Drug Administration (FDA) had approved Restylane Lyft with Lidocaine for chin augmentation in adults with mild-to-moderate chin retrusion, following positive clinical trial results showing sustained improvement and high satisfaction rates for up to 12 months. This regulatory milestone expands the Restylane portfolio’s approved uses in the U.S., potentially enhancing Galderma’s presence in the highly competitive aesthetic...

Geberit AG recently announced its third-quarter 2025 results, reporting sales of CHF 782.5 million and net income of CHF 155.8 million, both higher than the previous year, and confirmed full-year guidance for 2025 with local currency net sales growth of around 4.5%. This combination of positive quarterly performance and reaffirmed outlook signals continued demand momentum and supports confidence in Geberit’s operational execution. We'll explore how Geberit's reaffirmed 2025 sales growth...

Roche Holding (SWX:ROG) shares traded actively after the company announced that its experimental therapy, fenebrutinib, reached primary goals in Phase III trials for relapsing and primary progressive multiple sclerosis. This strengthens its neurology pipeline. At the same time, Roche reported that Gazyva achieved clinically meaningful success in a pivotal study for systemic lupus erythematosus. These milestones could open new market opportunities and elevate Roche's growth profile in the...

UBS Group AG recently completed an upsized multi-billion dollar debt tender offer, increasing its maximum purchase consideration from US$4 billion to US$8.6 billion and accepting US$7.67 billion in principal across several note series for buyback. This large-scale reduction of outstanding debt is an important move aimed at optimizing UBS's capital structure and potentially lowering future interest expenses. We'll explore how UBS Group’s sizeable debt buyback could influence its investment...

Most readers would already be aware that Huber+Suhner's (VTX:HUBN) stock increased significantly by 32% over the past...

Stock pickers are generally looking for stocks that will outperform the broader market. Buying under-rated businesses...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Key Insights Significant control over OC Oerlikon by private companies implies that the general public has more power...

On November 5, 2025, Swisscom AG released earnings results for the nine months ended September 30, 2025, reporting sales of CHF 11.18 billion, up from CHF 8.16 billion the previous year. While revenue grew significantly, Swisscom's net income and basic earnings per share both declined from the prior period, reflecting mixed operational trends. With earnings showing increased top-line growth but lower profitability, we explore how these results impact Swisscom's broader investment...

Straumann Holding (SWX:STMN) shares have been in focus after the company revealed a new strategic partnership with Smartee Denti-Technology. This collaboration will combine Straumann’s global dental reach and Smartee’s technical expertise to accelerate innovation in clear aligners. See our latest analysis for Straumann Holding. Straumann Holding’s share price has jumped sharply following its strategic alliance with Smartee Denti-Technology, recording an 18.5% share price return over the past...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...

The analysts covering SKAN Group AG ( VTX:SKAN ) delivered a dose of negativity to shareholders today, by making a...

Key Insights Using the 2 Stage Free Cash Flow to Equity, SoftwareOne Holding fair value estimate is CHF13.45...

Earlier this year, Avolta announced a series of major new retail contracts and developments at JFK Airport’s Terminal 8, including a mix of luxury global boutiques, a pre-loved luxury shop, and stores echoing New York City’s character, in partnership with Dufry, HMSHost, Hudson, Unibail-Rodamco-Westfield Airports, American Airlines, and the Port Authority of New York and New Jersey. This initiative is part of a US$125 million redevelopment within a wider US$19 billion transformation of JFK...

On October 30, 2025, SIG Group AG announced its earnings guidance for 2026, projecting revenue growth of 0-2% at constant currency and resin, and confirmed plans to reinstate its dividend with a 30%-50% payout ratio for the year ending December 2026 following a dividend pause in 2025. This cautious outlook, coupled with the planned return to dividend payments, provides shareholders with greater clarity on expected performance and capital return policy amid ongoing subdued market...

Barry Callebaut (SWX:BARN) released its full-year earnings, revealing sales climbed to CHF 14.8 billion, up from the previous year. However, net income dipped slightly. Investors are examining what these numbers mean for future growth. See our latest analysis for Barry Callebaut. Barry Callebaut’s latest earnings drop came alongside a surge in its share price, with a standout 20.1% gain over the past week and 25.5% return in the last three months. This hints at renewed optimism for the...

Novartis (SWX:NOVN) delivered a one-two punch this week by reporting stronger earnings and unveiling new data from its Phase III ianalumab studies in Sjogren's disease at a top rheumatology conference. Both updates are attracting investor attention. See our latest analysis for Novartis. After a steady climb most of the year, Novartis shares are showing renewed momentum, with a 16.92% year-to-date share price return and a 1.84% bump following this week’s headline-grabbing earnings and...

Sensirion recently held a groundbreaking ceremony for a new 11,000 m² high-tech production facility in Stafa, Switzerland, designed to address capacity constraints and support future advances in cleanroom manufacturing for the semiconductor industry. By also launching the versatile SGM5304 gas meter module and securing additional land for offices, the company is showcasing both long-term operational commitment and innovation in smart metering solutions to meet the evolving needs of global...

Adecco Group AG recently released its third-quarter 2025 results, reporting sales of €5.78 billion and net income of €89 million, while also announcing that Coram Williams will step down as CFO to be succeeded by Valentina Ficaio in January 2026. The leadership change comes as Adecco faces flat sales growth but lower profits, positioning the company for a new phase in financial management amid evolving market conditions. We'll consider how the appointment of a new CFO, alongside recent...

Bachem Holding AG announced that Anne-Kathrin Stoller will become its new CEO on January 1, 2026, following the departure of Thomas Meier after over three decades with the company. Stoller's extensive experience across multiple leadership roles at Bachem, including her recent tenure as Chief Operating Officer Americas, positions her as a leader with deep company and industry knowledge. With Stoller set to bring her operational expertise to the CEO position, we'll explore how this leadership...

Julius Bär Gruppe recently received regulatory approval to open a dedicated branch of Bank Julius Baer Europe Ltd. in Lisbon, Portugal, with the new office set to begin serving ultra-high and high-net-worth clients in early 2026. This move underscores Julius Bär's ongoing commitment to expanding its European footprint and supporting clients with an established, locally-based team while maintaining leadership continuity. We'll explore how establishing a regulated presence in Lisbon could...

Galderma Group (SWX:GALD) received FDA approval for Restylane Lyft with Lidocaine, now cleared for chin augmentation in adults. Backed by pivotal trial data, this move further broadens Restylane Lyft’s indications in the US market. See our latest analysis for Galderma Group. Galderma Group’s FDA win added fresh momentum to its already impressive run this year. Recent gains have kept investor attention squarely on the company’s growth story. The stock’s 47.6% year-to-date share price return...

Temenos (SWX:TEMN) has drawn fresh attention after a shift in its recent stock movement. Investors are closely watching how the company’s performance metrics and market sentiment could shape its outlook in the coming months. See our latest analysis for Temenos. Temenos has seen renewed momentum lately, with the share price climbing 14% over the past month and posting a 15% year-to-date gain. While its one-year total shareholder return stands at an impressive 27%, it is still working to...